Gout: diagnosis and management

Supporting evidence

• Other supporting evidence

• Methods (PDF 742 KB)

  Published:

  29 June 2022

• Appendix 1: Multimorbidities project (PDF 986 KB)

  Published:

  29 June 2022

• Evidence review

• Evidence reviews - June 2022

• A: Patient information (PDF 759 KB)

  Published:

  09 June 2022

• B: What signs and symptoms indicate gout as a possible diagnosis? (PDF 585 KB)

  Published:

  09 June 2022

• C: What are the most accurate and cost-effective approaches to diagnosing gout, in particular serum urate level compared with joint aspiration? (PDF 995 KB)

  Published:

  09 June 2022

• D: Pharmacological and non-pharmacological interventions for managing gout flares (PDF 1.73 MB)

  Published:

  09 June 2022

• E: Which people with gout should be offered a urate-lowering therapy (PDF 982 KB)

  Published:

  09 June 2022

• F: Timing of urate-lowering therapy in relation to a flare in people with gout (PDF 854 KB)

  Published:

  09 June 2022

• G: Urate-lowering therapies for the long-term management of gout (PDF 3.02 MB)

  Published:

  09 June 2022

• H: Colchicine, NSAIDs, corticosteroids and IL-1 inhibitors for the prevention of gout flares during the initiation or titration of urate-lowering therapy (PDF 860 KB)

  Published:

  09 June 2022

• I: Diet and lifestyle modifications for managing gout (PDF 1.18 MB)

  Published:

  09 June 2022

• J: Treat-to-target management (PDF 1004 KB)

  Published:

  09 June 2022

• K: The best serum urate level target to use when treating-to-target in gout? (PDF 515 KB)

  Published:

  09 June 2022

• L: Optimum frequency of monitoring (PDF 697 KB)

  Published:

  09 June 2022

• M: Follow-up for people with gout after a gout flare (PDF 534 KB)

  Published:

  09 June 2022

• N: Referral to specialist services (PDF 478 KB)

  Published:

  09 June 2022

• O: Surgical excision of tophi (PDF 502 KB)

  Published:

  09 June 2022